Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome
Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | Russian |
| 出版事項: |
«FIRMA «SILICEA» LLC
2004-12-01
|
| シリーズ: | Российский кардиологический журнал |
| 主題: | |
| オンライン･アクセス: | https://russjcardiol.elpub.ru/jour/article/view/2326 |